Novo Nordisk’s (NOVOB DC) oral semaglutide demonstrates potential to be the first oral GLP-1 RA for children and adolescents with type 2 diabetes; trial demonstrated a statistically significant and superior reduction in blood sugar by 0.83% vs placebo

Novo Nordisk's recent trial results for oral semaglutide, aiming to be the first oral GLP-1 receptor agonist for children and adolescents with type 2 diabetes, show promise with a significant reduction in blood sugar versus placebo.

Newsquawk StaffPublished 23 Apr 2026, 09:36 UTCOn the live feed at 09:16 UTC — 2 more headlines followed before this page went public

Newsquawk headlinesUTC

09:22

A large coalition of crypto companies and trade associations urged the Senate Banking Committee to “swiftly” schedule a markup of legislation that would overhaul the market structure of the financial system, Punchbowl reports

09:21

[MARKET ANALYSIS] PMIs initially helped fixed income off lows, but an inflationary UK release has superseded

09:16

Novo Nordisk’s (NOVOB DC) oral semaglutide demonstrates potential to be the first oral GLP-1 RA for children and adolescents with type 2 diabetes; trial demonstrated a statistically significant and superior reduction in blood sugar by 0.83% vs placebo

09:07

New York Mayor Mamdani reportedly to consider delaying pension fund payments, NYT reports

09:03

[MARKET ANALYSIS] European bourses mostly lower; Nestle +7% post-earnings

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free

Free. No signup, no card.

Context

This advancement not only supports Novo's pipeline but may also bolster its competitive stance in the diabetes market, potentially influencing investor sentiment and further product development.

All markets · last 90 days

Recent headlines that moved markets

EQUITIES/8 Sept · 05:24 UTC

Saudi Energy Minister says a number of energy facilities and utilities were hit; are temporarily halting some operations.

Equity indices, after we published−0.3%

Modest downside seen across equity futures as energy prices tick higher.

ENERGY/8 Sept · 05:23 UTC

Saudi Energy Minister says a number of energy facilities and utilities were hit; are temporarily halting some operations.

Brent Nov'26, after we published+1.0%

ENERGY/3 Sept · 08:03 UTC

Russian President Putin says that Russia and Ukraine should agree first; he notes that there is an opportunity to reach a peace agreement.

with Brent Nov, after we published−1.3%

EQUITIES/3 Sept · 04:54 UTC

North Korea stripped references to "peaceful unification" with South Korea from the charter of its ruling Workers' Party of Korea, according to Yonhap.

Equity indices, after we published−3.3%

EQUITIES/1 Sept · 16:17 UTC

Initial reports of an American attack on Iran, reports i24's Stein.

ES, after we published−0.2%

ENERGY/1 Sept · 16:17 UTC

Initial reports of an American attack on Iran, reports i24's Stein.

- Brent (V6), after we published+1.2%

Newsquawk Daily

Get both market opens in your inbox.

This note and the other one — the EU open and the US open, every business day, written by the desk. No account needed.

Related headlines

The whole workspace, free to try.

© 2026 Newsquawk. All rights reserved.